In November, as the Editor ofBMC肾脏病，我很高兴参加Kidney Week Annual Meeting。由美国肾脏病学会（ASN）组织。这次为期四天的会议由14,000多名国际代表参加，并在华盛顿市中心的沃尔特·E·华盛顿广大会议中心主持。

Kidney Week began with 10 early programs, followed by an Annual Meeting that was packed with plenary talks, clinical sessions, educational symposia, and poster sessions. Organized around the sessions were meetings withBMC肾脏病编辑ial Board Members谁同意与我见面。

Each day started with a series of state-of-the-art lectures including:

• 詹妮弗·杜德纳教授,University of California, Berkeley, on“Rewriting the code of life: the future of genome editing”
• Nobel Prize Laureate迈克尔·杨教授,Rockefeller University, on“Genes controlling sleep and circadian rhythms”
• 塞格威™ inventor Dean Kamen (DEKA Research & Development Corp.) and nephrologistsDr. Bruce Culleton(CVS Health), andDr. Tod Ibrahim(美国肾脏病学会) on“关于肾脏护理创新和转变的观点”
• Dr. Danielle Ofri,NYU School of Medicine, on“What patients say, what doctors hear”

The daily programs were crammed with cutting-edge research covering all areas of nephrology and its crossovers with other areas of medicine. Here are some of my highlights.

State-of-the-art lecture: Innovation and Transformation in Kidney Care

“七十六年后，我们的口袋里携带一台功能更强大的计算机，但主要依靠相同的技术来治疗中心透析中的肾衰竭”–Tod Ibrahim

发明家迪恩·卡门（Dean Kamen）和肾脏科医生布鲁斯·库雷顿（Bruce Culleton）博士和托德·易卜拉欣（Tod Ibrahim）博士的最先进的演讲是最先进的演讲，他们将超过8.5亿肾脏患者在全球范围内遇到的健康状况不佳的问题背景下来；种族不平等，可以进入家庭透析；在患者死于移植等候名单时，丢​​弃了可用的肾脏同种异体移植物。解决该领域的这些问题的进展似乎已经停滞不前，易卜拉欣命名为政府和投资者作为贡献者的资金不足。

However, the overall feeling was optimistic. The speakers were enthusiastic about how technology could revolutionize future nephrology care, and how initiatives such as推进美国肾脏健康could help bring investment into future technologies. Furthermore, the setup of the USAdvanced Regenerative Manufacturing Institutehas brought the development of a system to induce pluripotent stem cells to generate segments of bone and ligament within 40 days. This begs the question: how can this area of developmental biology influence the manufacture of kidneys and other organs for transplantation?

Clinical Practice Session: Pregnancy Outcomes and Kidney Disease

I attendedBMC肾脏病Section Editor,Giorgina Piccoli博士‘s (University of Torino, Italy) talk on“患有慢性肾脏疾病和肾脏移植女性的生殖健康”。与其他人群相比，患者患有透析和慢性肾脏疾病的风险令人担忧，患者患有透析和慢性肾脏疾病的风险更高的风险和过早分娩的风险相比，与其他人群相比。但是，听到Piccoli博士如何处理这些情况以及她如何重视避孕和性健康咨询以及与女性患者的开放沟通，了解她的患者的需求和需求，这令人鼓舞和鼓舞。Dr. Michelle Hladunewich, Sunnybrook Research Institute, Canada, offered a positive outlook for the future for women on dialysis who hoped for a successful pregnancy. Dr. Hladunewich explained that when a patient falls pregnant whilst being treated with dialysis, the risk of premature delivery can be lowered with certain interventions such as careful attention to clearance rates and induction of labor. With Canada being one of the world’s leaders in live birth rates for women on hemodialysis, perhaps there are some important lessons to be learned here?

ASN’s next Kidney Week meeting will take place in Denver, Colorado on the20^th-25^th2020年10月。TheBMC肾脏病team certainly look forward to attending future Kidney Week meetings.